Multimodal discovery of a pathogenic B-cell-dependent T-cell state in multiple sclerosis
Brain · 09.09.2026
DOI: 10.1093/brain/awag303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain, online erschienen am 09.09.2026. Verfasst von Redwan Farooq und 9 weiteren Autor:innen. Beteiligte Einrichtung: Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Aims2Cure, Oak Foundation, Medical Research Council.
Abstract (Originalsprache)
B-cell-depleting therapies in multiple sclerosis (MS) have transformed disease management, yet the immunological mechanisms linking B cells to chronic compartmentalized CNS inflammation, the key pathological driver of disability accrual, remain poorly defined. Here, we leverage anti-CD20 therapy as an in vivo perturbational probe to disentangle MS immunobiology. We combine longitudinal, high-dimensional multimodal immune profiling in patients initiating ocrelizumab with a novel machine learning pipeline to resolve treatment-induced shifts in continuous immune cell states, revealing treatment-associated modulation of shared biological processes that act across the boundaries of discretely partitioned cell types. We identify a distinct chronically activated, proinflammatory–cytotoxic T-cell state with CNS-homing properties that is selectively depleted following B-cell ablation. Importantly, across independent datasets, the same T-cell state is enriched in the circulation of patients with clinically aggressive relapsing disease, in CSF-enriched expanded clonotypes, including a subset with proven Epstein–Barr virus specificity, and in chronically inflamed lesion rims in end-stage MS. Finally, we demonstrate that blockade of lymphocyte trafficking across the blood–brain barrier with the anti-integrin α4 therapy natalizumab leads to enrichment of this cell state in the circulation, demonstrating a mechanistically concordant effect across distinct high-efficacy MS therapies. Together, our findings support a B-cell-dependent pathogenic T-cell state, which links peripheral immune activation to CNS-compartmentalized smouldering neuroinflammation across disease stages. Direct therapeutic manipulation of this T-cell state might represent a key opportunity for targeting chronic neuroinflammation and facilitate a strategic shift away from broad immune cell ablation.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nuffield Department of Clinical Neurosciences, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
- MRC Translational Immune Discovery Unit, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, OX3 9DS, UK.
- Department of Neurology, Oxford University Hospitals NHS Foundation Trust, John Radcliffe Hospital, Oxford, OX3 9DU, UK.
- Department of Neurology, St. Josef-Hospital, Ruhr University Bochum, Bochum, 44801, Germany.
- Institute of Computational Biology, Helmholtz Munich, Munich, 80939, Germany.
- TUM School of Life Sciences Weihenstephan, Technical University of Munich, Munich, 80333, Germany.
ORCID-Profile: Marco Pisa
Förderung
- Aims2Cure
- Oak Foundation
- Medical Research Council
- Association of British Neurologists
- Guarantors of Brain
Zitieren
APA
Farooq, R., Cutler, B., Pisa, M., Balaram Kuttikkatte, S., Palace, J., DeLuca, G. C., Gold, R., Theis, F. J., Fugger, L., & Attfield, K. E. (2026). Multimodal discovery of a pathogenic B-cell-dependent T-cell state in multiple sclerosis. Brain. https://doi.org/10.1093/brain/awag303
Vancouver
Farooq R, Cutler B, Pisa M, Balaram Kuttikkatte S, Palace J, DeLuca GC, et al. Multimodal discovery of a pathogenic B-cell-dependent T-cell state in multiple sclerosis. Brain. 2026. doi:10.1093/brain/awag303
BibTeX
@article{Farooq2026,
author = {Farooq, Redwan and Cutler, Brian and Pisa, Marco and Balaram Kuttikkatte, Subita and Palace, Jacqueline and DeLuca, Gabriele C and Gold, Ralf and Theis, Fabian J and Fugger, Lars and Attfield, Kathrine E},
title = {Multimodal discovery of a pathogenic B-cell-dependent T-cell state in multiple sclerosis},
journal = {Brain},
year = {2026},
doi = {10.1093/brain/awag303}
}
EUVIMED